Nakamura Clinic, Kita-Kyushu, Japan.
Pharmacol Res. 2010 May;61(5):460-5. doi: 10.1016/j.phrs.2009.12.002. Epub 2009 Dec 24.
Niemann-Pick C1-like 1 (NPC1L1) protein is identified as a key molecule of cholesterol absorption into the intestine. Although there is a controversy about the association between sitosterol levels and cardiovascular disease (CVD), cholesterol absorption may contribute to the increased risk for CVD because increased levels of sitosterol, a marker of cholesterol absorption, are associated with future cardiovascular events in high-risk patients. However, which anthropometric and metabolic variables could regulate serum levels of sitosterol in humans and whether serum sitosterol levels might reflect transport function of NPC1L1 are largely unknown. In this study, we first investigated the independent determinants of serum sitosterol levels in apparently healthy patients not taking lipid-lowering agents. We next examined the effects of angiotensin II on NPC1L1 gene and protein expression in differentiated Caco-2 cells. Seventy apparently health patients not taking lipid-lowering agents (28 men and 42 women, mean age 73.7+/-10.1 years old) underwent a complete history and physical examination, determination of blood chemistries, including serum levels of sitosterol. Univariate regression analysis showed that serum levels of sitosterol were associated with low-density-lipoprotein (LDL)-cholesterol (r=0.284, p=0.021) and use of the renin-angiotensin system (RAS) inhibitors (r=-0.289, p=0.018). By the use of multiple stepwise regression analyses, use of RAS inhibitors (p=0.025) was remained significant independently. Further, angiotensin II was found to up-regulate NPC1L1 mRNA and protein levels in Caco-2 cells, which were completely blocked by an angiotensin II type 1 receptor blocker or an anti-oxidant, N-acetylcysteine. The present study suggests the possible involvement of RAS in NPC1L1 expression in vitro and cholesterol absorption in humans.
NPC1L1 蛋白被鉴定为胆固醇吸收进入肠道的关键分子。虽然关于植物固醇水平与心血管疾病(CVD)之间的关联存在争议,但胆固醇吸收可能会增加 CVD 的风险,因为高水平的植物固醇是胆固醇吸收的标志物,与高危患者的未来心血管事件相关。然而,哪些人体测量和代谢变量可以调节血清植物固醇水平,以及血清植物固醇水平是否可以反映 NPC1L1 的转运功能,在很大程度上尚不清楚。在这项研究中,我们首先调查了未服用降脂药物的貌似健康患者血清植物固醇水平的独立决定因素。我们接下来研究了血管紧张素 II 在分化的 Caco-2 细胞中对 NPC1L1 基因和蛋白表达的影响。70 名未服用降脂药物的貌似健康患者(28 名男性和 42 名女性,平均年龄 73.7+/-10.1 岁)接受了完整的病史和体格检查,测定了血液化学物质,包括血清植物固醇水平。单变量回归分析显示,血清植物固醇水平与低密度脂蛋白(LDL)-胆固醇(r=0.284,p=0.021)和肾素-血管紧张素系统(RAS)抑制剂的使用(r=-0.289,p=0.018)相关。通过多元逐步回归分析,RAS 抑制剂的使用(p=0.025)仍然是独立的显著因素。此外,血管紧张素 II 被发现可上调 Caco-2 细胞中 NPC1L1 mRNA 和蛋白水平,该作用可被血管紧张素 II 型 1 受体阻滞剂或抗氧化剂 N-乙酰半胱氨酸完全阻断。本研究提示 RAS 可能参与 NPC1L1 在体外的表达和人类胆固醇吸收。